Cassava Sciences Files 8-K on Financials

Ticker: FLNA · Form: 8-K · Filed: May 8, 2025 · CIK: 1069530

Cassava Sciences INC 8-K Filing Summary
FieldDetail
CompanyCassava Sciences INC (FLNA)
Form Type8-K
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

TL;DR

Cassava Sciences dropped an 8-K updating its financial condition and results. Check it out.

AI Summary

Cassava Sciences, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, as well as presenting financial statements and exhibits. The company, previously known as Pain Therapeutics Inc., is incorporated in Delaware and headquartered in Austin, Texas.

Why It Matters

This filing provides an update on Cassava Sciences' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant financial and operational updates that may impact a company's stock price, requiring careful investor review.

Key Players & Entities

FAQ

What specific financial statements and exhibits are being filed with this 8-K?

The filing indicates that 'Financial Statements and Exhibits' are included as part of Item 9.01, but the specific details of these documents are not provided in the provided text.

What is the primary reason for Cassava Sciences filing this 8-K report?

The 8-K is filed to report on the company's 'Results of Operations and Financial Condition' and to present 'Financial Statements and Exhibits'.

When was Cassava Sciences, Inc. previously known by another name?

The company was formerly known as Pain Therapeutics Inc., with a date of name change on March 9, 2000.

Where are Cassava Sciences, Inc.'s principal executive offices located?

The principal executive offices are located at 6801 N Capital of Texas Highway, Building 1; Suite 300, Austin, Texas 78731.

What is Cassava Sciences' fiscal year end?

Cassava Sciences' fiscal year ends on December 31.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 8, 2025 regarding CASSAVA SCIENCES INC (FLNA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing